Autor segons l'article: Alegret, JM; Viñolas, X; Romero-Menor, C; Pons, S; Villuendas, R; Calvo, N; Pérez-Rodon, J; Sabaté, X
Departament: Medicina i Cirurgia
Autor/s de la URV: Alegret Colomé, Josep Maria
Paraules clau: Weight gain Trend study Treatment outcome Time factors Tertiary health care Task-force Spain Sotalol Sinus rhythm Rhythm control Registries Rate control Prospective studies Propafenone Priority journal Prevalence Prescription Practice guidelines as topic Practice guideline Population research Physician's practice patterns Middle aged Management Male Major clinical study Maintenance Humans Human Heart-rhythm-association Heart left ventricle ejection fraction Heart atrium fibrillation Health care utilization Health care surveys Guideline adherence Follow-up Follow up Flecainide Female External cardioversion Evidence-based medicine European-society Embolism Electrical cardioversion Electric countershock Diabetes mellitus Comorbidity Collaboration Chi-square distribution Cardioversion Cardiology committee Atrial fibrillation Article Antiarrhythmic agent Anti-arrhythmia agents Amiodarone American-college Aged Age factors Adult
Resum: The purpose of the present study was to assess the trends in the use of ECV following published studies that had compared rhythm and rate control strategies on atrial fibrillation (AF), and the recommendations included in the current clinical practice guidelines.The REVERCAT is a population-based assessment of the use of electrical cardioversion (ECV) in treating persistent AF in Catalonia (Spain). The initial survey was conducted in 2003 and the follow-up in 2010.We observed a decrease of 9% in the absolute numbers of ECV performed (436 in 2003 vs. 397 in 2010). This is equivalent to 27% when considering population increases over this period. The patients treated with ECV in 2010 were younger, had a lower prevalence of previous embolism, a higher prevalence of diabetes, and increased body weight. Underlying heart disease factors indicated, in 2010, a higher proportion of NYHA ? II and left ventricular ejection fraction <30%. We observed a reduction in the number of ECV performed in 16 of the 27 (67%) participating hospitals. However, there was an increase of 14% in the number of procedures performed in tertiary hospitals, and was related to the increasing use of ECV as a bridge to AF ablation. Considering the initial number of patients treated with ECV, the rate of sinus rhythm at 3 months was almost unchanged (58% in 2003 vs. 57% in 2010; p=0.9) despite the greater use of biphasic energy in 2010 and a similar prescription of anti-arrhythmic drugs.Although we observed a decrease in the number of ECVs performed over the 7 year period between the two studies, this technique remains a common option for treating patients with persistent AF. The change in the characteristics of candidate patients did not translate into better outcomes.
Àrees temàtiques: Saúde coletiva Psicología Medicina iii Medicina ii Medicina i Matemática / probabilidade e estatística Interdisciplinar Farmacia Educação física Ciências biológicas ii Ciências biológicas i Cardiology and cardiovascular medicine Cardiac & cardiovascular systems Biotecnología
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
ISSN: 14712261
Adreça de correu electrònic de l'autor: josepmaria.alegret@urv.cat
Identificador de l'autor: 0000-0002-6117-5512
Data d'alta del registre: 2024-02-10
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/1471-2261-12-42
Referència a l'article segons font original: Bmc Cardiovascular Disorders. 12 (): 42-
Referència de l'ítem segons les normes APA: Alegret, JM; Viñolas, X; Romero-Menor, C; Pons, S; Villuendas, R; Calvo, N; Pérez-Rodon, J; Sabaté, X (2012). Trends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice. Bmc Cardiovascular Disorders, 12(), 42-. DOI: 10.1186/1471-2261-12-42
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
DOI de l'article: 10.1186/1471-2261-12-42
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2012
Tipus de publicació: Journal Publications